Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337272
Status:
TERMINATED
Last Update Posted:
2011-08-22
First Post:
2006-06-13
Brief Title:
Treating Chronic Insomnia in Breast Cancer Patients
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Accelerated Community Oncology Research Network
Study Overview
Official Title:
Phase IV Treatment of Chronic Insomnia in Patients With Breast Cancer Following Completion of Chemotherapy
Status:
TERMINATED
Status Verified Date:
2011-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to evaluate the effectiveness of ramelteon 8mgs in the treatment of insomnia in patients that have completed their first chemotherapy treatment for breast cancer
Detailed Description:
Phase IV randomized double-blind placebo-controlled parallel-group study to assess the efficacy of ramelteon 8mgs in the treatment of insomnia in patients with breast cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None